Filing Details

Accession Number:
0001022079-22-000031
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-28 19:35:31
Reporting Period:
2022-02-24
Accepted Time:
2022-02-28 19:35:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222679 E Michael Prevoznik 500 Plaza Drive
Secaucus NJ 07094
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-24 1,669 $126.26 37,144 No 4 S Direct
Common Stock Acquisiton 2022-02-24 2,741 $0.00 39,885 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualifed Stock Option (right to buy) Acquisiton 2022-02-24 13,301 $0.00 13,301 $127.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,301 2032-02-24 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,307 Indirect 401(k)/SDCP
Footnotes
  1. The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2020.
  2. Represents an award of restricted share units.
  3. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
  4. The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.